+21.1%
GSK vs Q
+75.8%
-54.7%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | Q | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.6% | -1.2% | +0.6% | -0.7% |
| 7D | +5.2% | +4.0% | +1.2% | +5.4% |
| 30D | +10.2% | -2.3% | +12.5% | +10.2% |
| 3M | -0.9% | -7.9% | +7.0% | -0.9% |
| 6M | +3.5% | -16.0% | +19.5% | +3.1% |
| YTD | +7.2% | +51.7% | -44.5% | +4.2% |
| 1Y | +12.0% | +28.3% | -16.3% | +10.6% |
| All | +21.1% | +75.8% | -54.7% | +19.4% |
Cumulative growth
Daily Returns
Daily percentage return beside Q.
Daily Out/Under-Performance
Portfolio return minus Q return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × Q return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded Q wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling